Time

Hall 1A

Hall 1B

09.00 - 09.30

Session 35

Ayliffe Lecture

Professor Andreas Voss, Professor of Infection Control, Canisius-Wilhelmina Hospital, Radboud University Nijmegen Medical Centre, The Netherlands

09.35 - 10.05

Session 36

European Prevalence Survey - England perspective: ECDC led point prevalence survey on healthcare associated infections and antimicrobial use in acute care hospitals

Dr Susan Hopkins, Healthcare Epidemiologist,  Health Protection Agency Consultant in Infectious Diseases & Microbiology, Royal Free Hampstead NHS Trust Honorary Senior Lecturer, UCL

The objectives are to:

• review preliminary data from Europe
• UK & Ireland - inter-country comparisons
• discuss where to next with HCAI surveillance & interventions
• explore what actions are required for antimicrobial stewardship

10.10 – 10.45

Session 37

Management of an international wide E. coli outbreak

Professor Dilys Morgan, Head, Gastrointestinal, Emerging and Zoonotic Infections, Health Protection Agency

The objectives are to:

• understand the complexities and challenges of dealing with an international outbreak
• identify the mechanisms for case finding on an international scale
• understand  international surveillance systems and control measures

Session 38

Surface coatings – a review of the evidence

Christopher Gush, Head of Clinical Innovation and Research, Royal College of General Practitioners*

The objectives are to:

• the rationale for antimicrobial surfaces in healthcare
• An overview of available antimicrobial surfaces
• Gaps in the evidence for the use of antimicrobial surfaces

10.45 - 11.30

REFRESHMENTS AND EXHIBITION VIEWING

11.30 - 12.05

Session 39

Are targets the friend or foe of surveillance?

Surveillance - Jennie Wilson, Deputy Director Infection Prevention and Control, Imperial College Healthcare NHS Trust

Target - Martin Kiernan, Nurse Consultant, Infection Prevention, Southport and Ormskirk Hospital NHS Trust

The objectives are to:

• briefly review current HCAI surveillance
• examine opportunities for developing effective surveillance activities
• discuss the use of surveillance data in performance management

Session 40

Pandemic influenza planning - a framework for an earthquake response

Julianne Munro, Clinical Nurse Specialist – Infection Presentation and Control, The Princess Margaret Hospital, Canterbury District Health Board

Christchurch, New Zealand

The objectives are to:

• outline the key strategies from a pandemic influenza action plan utilized for disaster management in a city extensively damaged  by several earthquakes in 2010 and 2011
• discuss the importance of a well established Coordinated Incident Management System when faced with a major natural disaster
• outline Infection Prevention and Control issues and solutions utilized in both hospitals and the community to deal with no running water and a non functioning sewage system
• review issues surrounding relocation, evacuation and setting up of welfare centres
• describe surveillance that supports the success of Infection Prevention and Control strategies implemented

12.10 - 12.45

Session 41

HOUDINI

Professor Heather Loveday, Principal Lecturer, University of West London

The objectives are to:

• explain the background to the HOUDINI nurse led protocol for the removal of indwelling urethral catheters
• describe the methods used in the HOUDINI implementation project
• discuss the problems and limitations associated with data collection in the 'real world'
• present the results of the first six months of the project
• provide an insight into the facilitators and barriers to the use of the HOUDINI protocols

Session 42

Are we too clean for our own good? - the hygiene hypothesis and its implications for Infection Prevention and Control

Professor Sally Bloomfield, Hon Professor London School of Hygiene and Tropical Medicine, Chairman International Scientific Forum on Home Hygiene, International Scientific Forum on Home Hygiene

The objectives are to:

• review current understanding about the link between microbial exposure and the development of allergies and other chronic inflammatory disorders
• review what is known about the nature of the microbial exposure required for “balanced” immune development
• consider the implications of current thinking about the hygiene hypothesis in relation to public strategies for infection prevention and control

12.45 – 14.15

REFRESHMENTS AND EXHIBITION VIEWING

14.20 - 14-55

Session 43

How to identify, expose, and challenge Bad Science
Dr Ben Goldacre, Author and Academic

The objectives are to:

• explore examples of "bad science"
• arm the audience with tools to spot and neutralise bad science

14.55 – 15.30

Session 44

Late Breaker Session

15.35

Close of Conference